Provided by Tiger Fintech (Singapore) Pte. Ltd.

SciSparc Ltd.

0.3080
+0.00220.72%
Post-market: 0.3078-0.0002-0.06%19:57 EDT
Volume:224.17K
Turnover:67.95K
Market Cap:3.46M
PE:-0.29
High:0.3100
Open:0.3100
Low:0.2973
Close:0.3058
Loading ...

SciSparc extends $2M loan to support AutoMax growth

TIPRANKS
·
27 Feb

Scisparc Extends $2 Million Loan to Support Automax's Growth Following Automax’s Entry Into Direct Import of Jac Electric Vehicles

THOMSON REUTERS
·
27 Feb

SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax’s Entry into Direct Import of JAC Electric Vehicles

GlobeNewswire
·
27 Feb

N2OFF to Acquire Biotech Firm MitoCareX Bio; Shares Fall

MT Newswires Live
·
26 Feb

N2off Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard to Treat Cancers

THOMSON REUTERS
·
26 Feb

N2OFF Signs Definitive Agreement to Acquire Next-Gen Computational Drug Discovery Company, Targeting Hard To Treat Cancers

GlobeNewswire
·
26 Feb

Scisparc Ltd: Suit Included Allegations of Breaches of Fiduciary Duties of Defendants Relating to Prior Acquisition of Pain Clinic Network

THOMSON REUTERS
·
18 Feb

Scisparc Ltd: Secures Favorable Settlement in Lawsuit Filed in Feb 2022 Against Six Former Directors

THOMSON REUTERS
·
18 Feb

Scisparc Ltd: as Part of Settlement, Co Is Entitled to $411,000 Payment From Defendants for Full Dismissal by Co of Alleged Claims

THOMSON REUTERS
·
18 Feb

SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology

GlobeNewswire
·
18 Feb

Scisparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

THOMSON REUTERS
·
04 Feb

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

GlobeNewswire
·
04 Feb

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

GlobeNewswire
·
04 Feb

SciSparc Gets 180-Day Nasdaq Extension to Regain Compliance With Minimum Bid Price Rule

MT Newswires Live
·
16 Jan

SciSparc granted 180-day extension to regain Nasdaq compliance

TIPRANKS
·
15 Jan

Scisparc Granted 180-Day Extension by Nasdaq to Regain Compliance With Minimum Bid Requirement

THOMSON REUTERS
·
15 Jan

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

GlobeNewswire
·
15 Jan

SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles

GlobeNewswire
·
13 Jan

SciSparc says MitoCareX expands research to pancreatic cancer

TipRanks
·
08 Jan

Scisparc: Mitocarex Bio Expands Research to Pancreatic Cancer Following Initial in-Vitro Positive Results

THOMSON REUTERS
·
07 Jan